Activation of MAPKs influences the expression of drug-metabolizing enzymes in primary human hepatocytes

General Physiology and Biophysics

Volumn 28, Issue 3, 2009, Pages 316-320

  Bachleda, Petr ^a   Vrzal, Radim ^b   Dvořák, Zdeněk ^b  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Cytochrome P450; Human hepatocytes; MAPKs; Xenoreceptors

Indexed keywords

ANISOMYCIN; CYTOCHROME P450 1A; CYTOCHROME P450 1A1; CYTOCHROME P450 2B6; CYTOCHROME P450 3A4; DIOXIN; DRUG METABOLIZING ENZYME; EPIDERMAL GROWTH FACTOR; GLUCURONOSYLTRANSFERASE 1A1; GLUTATHIONE TRANSFERASE A1; GLUTATHIONE TRANSFERASE A2; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PHENOBARBITAL; PROTEIN SULT1B2; PROTEIN SULT2A1; PROTEIN UGT2B17; RIFAMPICIN; SORBITOL; SULFOTRANSFERASE 1A1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CELL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

ANISOMYCIN; ARYL HYDROCARBON HYDROXYLASES; DIOXINS; ENZYME ACTIVATION; ENZYME ACTIVATORS; EPIDERMAL GROWTH FACTOR; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLUCURONOSYLTRANSFERASE; GLUTATHIONE TRANSFERASE; HEPATOCYTES; HUMANS; PHENOBARBITAL; RIFAMPIN; RNA, MESSENGER; SORBITOL; SULFOTRANSFERASES;

EID: 72949083135     PISSN: 02315882     EISSN: None     Source Type: Journal    
DOI: 10.4149/gpb_2009_03_316     Document Type: Article

References (11)

1. Bogoyevitch M. A., Ketterman A. J., Sugden P. H. (1995): Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J. Biol. Chem. 270, 29710-29717; doi: 10.1074/jbc.270.50.29710
2. Donato M. T., Lahoz A., Castell J. V., Gomez-Lechon M. J. (2008): Cell lines: a tool for in vitro drug metabolism studies. Curr. Drug Metab. 9, 1-11; doi:10.2174/ 138920008783331086
3. Henklova P., Vrzal R., Papouskova B., Bednar P., Jancova P., Anzenbacherova E., Ulrichova J., Maurel P., Pavek P., Dvorak Z. (2008a): SB203580, a pharmacological inhibitor of p38 MAP kinase transduction pathway activates ERK and JNK MAP kinases in primary cultures of human hepatocytes. Eur. J. Pharmacol. 593,16-23; doi:10.1016/ j.ejphar.2008.07.007
4. Henklova P., Vrzal R., Ulrichova J., Dvorak Z. (2008b): Role of mitogen-activated protein kinases in aryl hydrocarbon receptor signaling. Chem. Biol. Interact. 172, 93-104; doi:10.1016/j.cbi.2007.12.005
5. Joiakim A., Mathieu P. A., Elliott A. A., Reiners J. J. (2004): Super-induction of CYP1A1 in MCF10A cultures by cycloheximide, anisomycin, and puromycin: a process independent of effects on protein translation and unrelated to suppression of aryl hydrocarbon receptor proteolysis by the proteasome. Mol. Pharmacol. 66, 936-947
6. Kyriakis J. M., Avruch J. (1996): Sounding the alarm: protein kinase cascades activated by stress and inflammation. J. Biol. Chem. 271, 24313-24316; doi:10.1074/ jbc.271.40.24313
7. Oesch-Bartlomowicz B., Oesch F. (2008): Phosphorylation of xenobiotic-metabolizing cytochromes P450. Anal. Bioanal. Chem. 392, 1085-1092; doi:10.1007/s00216- 008-2315-2322
8. Pascussi J. M., Gerbal-Chaloin S., Duret C, Daujat-Chavanieu M., Vilarem M. J., Maurel P. (2008): The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences. Annu. Rev. Pharmacol. Toxicol. 48, 1-32; doi:10.1146/annurev.pharmtox.47.120505.105349
9. Pavek P., Dvorak Z. (2008): Xenobiotic-induced transcriptional regulation of xenobiotic metabolizing enzymes of the cytochrome P450 superfamily in human extrahepatic tissues. Curr. Drug Metab. 9, 129-143; doi:10.2174/ 138920008783571774
10. Roberts P. J., Der C. J. (2007): Targeting the Raf-MEK-ERK mitogenactivated protein kinase cascade for the treatment of cancer. Oncogene 26,3291-3310; doi:10.1038/sj.onc.l210422
11. Vrzal R., Daujat-Chavanieu M., Pascussi J. M., Ulrichova J., Maurel R, Dvorak Z. (2008): Microtubules-interfering agents restrict aryl hydrocarbon receptor-mediated CYP1A2 induction in primary cultures of human hepatocytes via c-jun-N-terminal kinase and glucocorticoid receptor. Eur. J. Pharmacol. 581, 244-254; doi:10.1016/ j.ejphar.2007.11.059 316